Learn how to comply with the EU AI Act when AI is used in GCP-critical eTMF contexts in part two of this series by Donatella Ballerini.
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
- Virtual Reality Endpoints Improve Measurement Of Patients' Real-World Benefit
- Can't-Miss Advice On Selecting Your First AI-Enabled Vendor
- The Site Perspective: Why Ambient AI Is The Missing Link In Clinical Trial Data Integrity
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Modernizing Research Through New Tech, Contracting, And Pricing
Meet the FDA's guidance on modernizing your clinical trials with a single-codebase solution that streamlines data capture, reduces delays, and simplifies compliance.
-
Shaping The Future Of eCOA User Acceptance Testing
Proactive planning by sponsors and early User Acceptance Testing (UAT) involvement in the eCOA design process can substantially improve study quality, efficiency, and consistency.
-
Enhancing Competitive Intelligence In Pharma With Comprehensive Data Analysis
Discover a unified platform that turns complex pharma data into clear, strategic insights, empowering teams to outpace competitors with evidence-backed decisions from pipeline to launch.
-
What Everest Group's RTSM Recognition Means For The Industry
RTSM is transforming from a basic operational tool into a strategic driver of trial efficiency. Learn why industry recognition signals a new era of innovation and competitive advantage.
-
Maximizing Clinical Data Insights With Advanced Analytics Platforms
To achieve drug approval, trials must collect, combine, and analyze diverse data sets that support operational, safety review, risk management, and other analyses crucial to development.
-
Benefits Of Using ePRO In Early Phase Studies
Discover how harnessing Patient Reported Outcomes electronically in early-phase trials can boost patient centricity, create more cost-effective operations, and help generate better data faster.
-
The Power Of Adaptive Learning
Delve into the details of this approach to training, which addresses common complaints, and how it holds promise for enhancing the efficiency and performance of clinical research staff.
-
Keep Up With These 5 Patient Engagement And Recruitment Trends
From decentralized trials to real world data, take a look at top trends, their impact on patient enrollment and more, as well as ways to stay ahead of the curve.
-
Addressing The Specific Complexities Of Oncology eCOA Clinical Trials
What are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
Why Use Scorecards To Make Vendor Selection Decisions
Scorecards enable structured, unbiased vendor selection by transforming complex clinical trial decisions into transparent, data-driven evaluations — ensuring operational excellence and regulatory compliance.